Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services.
Neobe Therapeutics has raised $2.3M in total funding. The most recent round was Seed. The last funding was announced in February 2024.
Neobe Therapeutics's investors include Innovate UK, 2048 Ventures, Deep Science Ventures, Cancer Research Horizons, Pioneer Group.
Neobe Therapeutics is headquartered in London, United Kingdom.
Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services.
Neobe Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neobe Therapeutics — Funding & Investors." VCBacked, February 29, 2024, https://www.vcbacked.co/company/neobe-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). Neobe Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/neobe-therapeutics
{{cite web |title=Neobe Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neobe-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated